Canadian Cancer Trials Group Bulletins

Ethics Regulatory


Important Changes to Canadian Cancer Trials Group's Ethics Requirements

ERG has updated our ethics website to contain comprehensive information regarding our policies on initial approval, trial modifications, trial websites, documentation requirements, safety reporting to the REB and more.

This includes information on revisions to the Product Monograph (PM) submission requirements and level of REB approval required for trials that are not NCI US-affiliated.

Please see the memo (http://www.ctg.queensu.ca/private/ethics/news.htm) and the updated website (http://www.ctg.queensu.ca/private/ethics/ethics/default.html) for further details.

If you have any questions, please don't hesitate to contact your centre's Ethics RA.